The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. CorMedix Inc shares valued at $1,565,670 were sold by Hurlburt Elizabeth on Nov 14 ’24. At $11.18 per share, Hurlburt Elizabeth sold 140,027 shares. The insider’s holdings dropped to 45,397 shares worth approximately $0.44 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hurlburt Elizabeth purchased 140,027 shares, netting a total of over 1,556,416 in proceeds.
Before that, Todisco Joseph had added 13,561 shares to its account. In a trade valued at $50,718, the Chief Executive Officer bought CorMedix Inc shares for $3.74 each. Upon closing the transaction, the insider’s holdings increased to 13,561 shares, worth approximately $3.42 million.
As published in their initiating research note from Rodman & Renshaw on August 26, 2024, CorMedix Inc [CRMD] has been a Buy and the price target has been revised to $13. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in early August. As of February 17, 2021, Needham has initiated its “Buy” rating for CRMD. Earlier on September 29, 2020, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for CRMD stock.
Analyzing CRMD Stock Performance
During the last five days, there has been a drop of approximately -2.81%. Over the course of the year, CorMedix Inc shares have jumped approximately 157.98%. Shares of the company reached a 52-week high of $13.85 on 10/29/24 and a 52-week low of $2.89 on 02/08/24. A 50-day SMA is recorded $10.34, while a 200-day SMA reached $6.28. Nevertheless, trading volume fell to 0.51 million shares from 0.56 million shares the previous day.
Support And Resistance Levels for CorMedix Inc (CRMD)
According to the 24-hour chart, there is a support level at 9.49, which, if violated, would cause prices to drop to 9.29. In the upper region, resistance lies at 9.85. The next price resistance is at 10.00. RSI (Relative Strength Index) is 42.41 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.40, which suggests the price will decrease in the coming days. Percent R is at 85.12%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
